OBJECTIVES: This study aimed to examine feasibility of testing and frequency of abnormal plasma glucose among dental patients in The Dental Practice-Based Research Network. METHODS: Eligible dental patients were ≥19 years old and had at least one American Diabetes Association-defined risk factor for diabetes mellitus or an existing diagnosis of diabetes or pre-diabetes. Random (fasting not required) plasma glucose was measured in standardized fashion using a commercial glucometer. Readings <70 or >300 mg/dl triggered re-testing. Patients with glucose ≥126 mg/dl were referred for medical follow-up. RESULTS: Of 498 subjects in 28 dental practices, 491 (98 %) consented and 418 (85.1 %) qualified for testing. Fifty-one patients (12.2 %) had diabetes; 24 (5.7 %) had pre-diabetes. Glucose ranged from 50 to 465 mg/dl. One hundred twenty-nine subjects (31 %) had readings outside the normal range; of these, 28 (6.7 %) had readings <80 mg/dl and 101 (24.2 %) had readings ≥126 mg/dl; in nine patients (seven with diabetes), glucose was >200 mg/dl. CONCLUSIONS: A significant proportion of patients tested had abnormal blood glucose. Routine glucose testing in dental practice of populations at risk or diagnosed with diabetes may be beneficial and community dental practices hold promise as settings for diabetes and pre-diabetes screening and monitoring. CLINICAL RELEVANCE: Results suggest that implementation of glucose measurement in dental practice may provide important clinical and health information for both patients and practitioners.
OBJECTIVES: This study aimed to examine feasibility of testing and frequency of abnormal plasma glucose among dental patients in The Dental Practice-Based Research Network. METHODS: Eligible dental patients were ≥19 years old and had at least one American Diabetes Association-defined risk factor for diabetes mellitus or an existing diagnosis of diabetes or pre-diabetes. Random (fasting not required) plasma glucose was measured in standardized fashion using a commercial glucometer. Readings <70 or >300 mg/dl triggered re-testing. Patients with glucose ≥126 mg/dl were referred for medical follow-up. RESULTS: Of 498 subjects in 28 dental practices, 491 (98 %) consented and 418 (85.1 %) qualified for testing. Fifty-one patients (12.2 %) had diabetes; 24 (5.7 %) had pre-diabetes. Glucose ranged from 50 to 465 mg/dl. One hundred twenty-nine subjects (31 %) had readings outside the normal range; of these, 28 (6.7 %) had readings <80 mg/dl and 101 (24.2 %) had readings ≥126 mg/dl; in nine patients (seven with diabetes), glucose was >200 mg/dl. CONCLUSIONS: A significant proportion of patients tested had abnormal blood glucose. Routine glucose testing in dental practice of populations at risk or diagnosed with diabetes may be beneficial and community dental practices hold promise as settings for diabetes and pre-diabetes screening and monitoring. CLINICAL RELEVANCE: Results suggest that implementation of glucose measurement in dental practice may provide important clinical and health information for both patients and practitioners.
Authors: David Edelman; Lloyd J Edwards; Maren K Olsen; Tara K Dudley; Amy C Harris; Dana K Blackwell; Eugene Z Oddone Journal: J Gen Intern Med Date: 2002-01 Impact factor: 5.128
Authors: Nazneem N Wahab; Elizabeth A Cowden; Neil J Pearce; Martin J Gardner; Heather Merry; Jafna L Cox Journal: J Am Coll Cardiol Date: 2002-11-20 Impact factor: 24.094
Authors: Shiela M Strauss; Marlena Vega; Helene D Clayton-Jeter; Sherry Deren; Mary Rosedale; David M Rindskopf Journal: Hisp Health Care Int Date: 2014
Authors: Shiela M Strauss; Mary Rosedale; Michael A Pesce; Caroline Juterbock; Navjot Kaur; Joe DePaola; Deborah Goetz; Mark S Wolff; Dolores Malaspina; Ann Danoff Journal: Point Care Date: 2014-12
Authors: Shiela M Strauss; Mary T Rosedale; Michael A Pesce; David M Rindskopf; Navjot Kaur; Caroline M Juterbock; Mark S Wolff; Dolores Malaspina; Ann Danoff Journal: Am J Public Health Date: 2015-02-25 Impact factor: 9.308
Authors: Kamaira H Philips; Shaoping Zhang; Kevin Moss; Katharine Ciarrocca; James D Beck Journal: J Am Dent Assoc Date: 2020-11-27 Impact factor: 3.634
Authors: Rodrigo Mariño; Andre Priede; Michelle King; Geoffrey G Adams; Maria Sicari; Mike Morgan Journal: BMC Endocr Disord Date: 2022-07-18 Impact factor: 3.263
Authors: Rahma Mungia; Ellen Funkhouser; Sonia K Makhija; Stephanie C Reyes; Rachel A Cohen; David L Cochran; Cyril Meyerowitz; D Brad Rindal; Valeria V Gordan; Jeffrey L Fellows; Meredith Trejo; Thomas W Oates; Jason D McCargar; Pamela A McMahon; Gregg H Gilbert Journal: J Am Board Fam Med Date: 2020 Sep-Oct Impact factor: 2.657